nivolumab,sotigalimab,paclitaxel
bms,apexigen
['prince', 'biomarker', 'pancreatic', 'bms', 'apexigen']
data from phase 2 prince trial funded by bms, &amp; in collab w/apexigen: biomarkers may predict better immunotherapy treatment outcomes for certain patients with pancreatic cancer. lead author , vp informatics #asco22 1/n
Founder of Cambridge BioPartners, Inc. I'm also @PearlF on Clubhouse.